1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole
- CAS
- 110963-63-8
- Formula
- C16H23N3O
- MW
- 273.37 g/mol
VQ-024588
Impurity reference standards
Bilastine impurities & reference standards
Characterised Bilastine impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
52reference materials
1nitrosamine impurities
2isotope-labelled
COAHPLC · NMR · MS on request
![1-(2-Ethoxyethyl)-2-(1-(2-ethoxyethyl)piperidin-4-yl)-1H-benzo[d]imidazole chemical structure](/media/structures/QBBWNKLKPPEZFB-UHFFFAOYSA-N.svg)
1-(2-Ethoxyethyl)-2-(1-(2-ethoxyethyl)piperidin-4-yl)-1H-benzo[d]imidazole
- CAS
- 2818982-86-2
- Formula
- C20H31N3O2
- MW
- 345.5 g/mol
VQ-024585
![1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride chemical structure](/media/structures/YOWRIDDXDCHTLL-UHFFFAOYSA-N.svg)
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride
- CAS
- 1841081-72-8
- Formula
- C16H24ClN3O
- MW
- 309.83 g/mol
VQ-024593
![2-(1-(2-Ethoxyethyl)piperidin-4-yl)-1H-benzo[d]imidazole chemical structure](/media/structures/MRRIXOYSHHPDBZ-UHFFFAOYSA-N.svg)
2-(1-(2-Ethoxyethyl)piperidin-4-yl)-1H-benzo[d]imidazole
- CAS
- 2807304-46-5
- Formula
- C16H23N3O
- MW
- 273.37 g/mol
VQ-024584
![2-(1-Nitrosopiperidin-4-yl)-1H-benzo[d]imidazole chemical structure](/media/structures/IHOBDEFDXZXTHP-UHFFFAOYSA-N.svg)
2-(1-Nitrosopiperidin-4-yl)-1H-benzo[d]imidazole
- CAS
- 2731008-04-9
- Formula
- C12H14N4O
- MW
- 230.27 g/mol
VQ-024587
![2-(2-(1-(4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazol-1-yl)ethan-1-ol chemical structure](/media/structures/POVJMUSSAISURP-UHFFFAOYSA-N.svg)
2-(2-(1-(4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazol-1-yl)ethan-1-ol
- CAS
- 202189-82-0
- Formula
- C30H40N4O2
- MW
- 488.7 g/mol
VQ-029440
![2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole chemical structure](/media/structures/MXKMEANVUFWYSG-UHFFFAOYSA-N.svg)
2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole
- CAS
- 202189-77-3
- Formula
- C32H44N4O2
- MW
- 516.7 g/mol
VQ-020963
2-(2-(4-Bromophenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole
- CAS
- 192775-97-6
- Formula
- C14H18BrNO
- MW
- 296.2 g/mol
VQ-029442
![2-(3-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid chemical structure](/media/structures/YQBLDZMARIUXJI-UHFFFAOYSA-N.svg)
2-(3-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid
- CAS
- 1215537-40-8
- Formula
- C28H37N3O3
- MW
- 463.6 g/mol
VQ-021833
![2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-N-methoxy-N,2-dimethylpropanamide chemical structure](/media/structures/ZCGYNXFWPGDWGI-UHFFFAOYSA-N.svg)
2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-N-methoxy-N,2-dimethylpropanamide
- CAS
- 1638785-18-8
- Formula
- C30H42N4O3
- MW
- 506.7 g/mol
VQ-029437
![2-(4-(2-(4-(1-(2-Methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid chemical structure](/media/structures/JLASWOVXUMSXND-UHFFFAOYSA-N.svg)
2-(4-(2-(4-(1-(2-Methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid
- CAS
- 2767508-98-3
- Formula
- C27H35N3O3
- MW
- 449.6 g/mol
VQ-020962
![2-(4-(2-(4-(1-(4-(2-Carboxypropan-2-yl)phenethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid chemical structure](/media/structures/KNKMPTISLKEIED-UHFFFAOYSA-N.svg)
2-(4-(2-(4-(1-(4-(2-Carboxypropan-2-yl)phenethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid
- CAS
- 2411093-91-7
- Formula
- C36H43N3O4
- MW
- 581.7 g/mol
VQ-020683
![2-(4-(2-(4-(1H-Benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid chemical structure](/media/structures/CBOACCSFNYMVHU-UHFFFAOYSA-N.svg)
2-(4-(2-(4-(1H-Benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic Acid
- CAS
- 2099128-83-1
- Formula
- C24H29N3O2
- MW
- 391.5 g/mol
VQ-024589
2-(4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenyl)ethanol
- CAS
- 361382-26-5
- Formula
- C16H23NO2
- MW
- 261.36 g/mol
VQ-029443
2-(4-(2-Bromoethyl)phenyl)-2-methylpropanoic Acid
- CAS
- 948552-52-1
- Formula
- C12H15BrO2
- MW
- 271.15 g/mol
VQ-035970
2-(4-(2-Chloroacetyl)phenyl)-N-methoxy-N,2-dimethylpropanamide
- CAS
- 1638785-15-5
- Formula
- C14H18ClNO3
- MW
- 283.75 g/mol
VQ-029441
2-(4-(2-Chloroacetyl)phenyl)-N,N,2-trimethylpropanamide
- CAS
- 3028279-52-6
- Formula
- C14H18ClNO2
- MW
- 267.75 g/mol
VQ-047582
4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate
- CAS
- 202189-76-2
- Formula
- C23H29NO4S
- MW
- 415.5 g/mol
VQ-035968
Methyl 2-(3-(2-chloroethyl)phenyl)-2-methylpropanoate
- CAS
- 2245209-60-1
- Formula
- C13H17ClO2
- MW
- 240.72 g/mol
VQ-029436
![Methyl 2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoate chemical structure](/media/structures/AWUXQUVYMUBJSG-UHFFFAOYSA-N.svg)
Methyl 2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoate
- CAS
- 1181267-38-8
- Formula
- C29H39N3O3
- MW
- 477.6 g/mol
VQ-021834
Methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate
- CAS
- 1638785-19-9
- Formula
- C13H15ClO3
- MW
- 254.71 g/mol
VQ-024581
Methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate
- CAS
- 1181267-33-3
- Formula
- C13H17ClO2
- MW
- 240.72 g/mol
VQ-024582
Methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate
- CAS
- 1181267-30-0
- Formula
- C20H24O5S
- MW
- 376.5 g/mol
VQ-047585
![Methyl2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)-1-hydroxyethyl)phenyl)-2-methylpropanoate](/media/pack/methyl2-4-2-4-1-2-ethoxyethyl-1h-benzodimidazol-2-ylpiperidin-1-yl-1-hydroxyethylphenyl-2.svg?v=3)
Methyl2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)-1-hydroxyethyl)phenyl)-2-methylpropanoate
- CAS
- 1638785-21-3
- Formula
- C29H39N3O4
- MW
- 493.65 g/mol
VQ-047587
FAQs — Bilastine impurities
Which Bilastine impurities do you supply?
We list 52 Bilastine-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Bilastine impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Bilastine impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Bilastine impurity standards
We reply within one business day with price, pack options, lead time and documentation.